Arcanum of mechanism of praziquantel against schistosomes

Abstract

Abstract:

This article reviews the mechanism of praziquantel against schistosomes briefly, points out the different effects of praziquantel on the different develop stages of schistosomes, which presents an oddity mode, and suggests the research on this oddity phenomenon.

Key words: Praziquantel, Schistosome, Mechanism

摘要：

本文简要综述吡喹酮抗血吸虫作用的机理，指出吡喹酮对血吸虫发育不同阶段有不同的作用，且呈现间隔变化的模式，并对这一奇特现象提出开展研究的建议。

关键词: 吡喹酮, 血吸虫, 机理

CLC Number:

R383.24

HUANG Yi-Xin. Arcanum of mechanism of praziquantel against schistosomes[J]. Chin J Schisto Control, 2010, 22(2): 101-104.

黄一心. 吡喹酮抗血吸虫作用机理的奥秘[J]. 中国血吸虫病防治杂志, 2010, 22(2): 101-104.

[1]	MU Qianqian, ZHOU Biying. Progress of researches on molecular mechanisms underlying helminth infection⁃mediated type 1/2 host immune responses [J]. Chinese Journal of Schistosomiasis Control, 2023, 35(5): 534-538.
[2]	CHENG Donghui, LI Zhongqiu, ZENG Wenbo, JIANG Tiange, GUO Yunhai, ZHANG Yi. Progress of researches on the role and mechanisms of non⁃coding RNA in Angiostrongylus cantonensis infection [J]. Chinese Journal of Schistosomiasis Control, 2023, 35(4): 407-412.
[3]	CHEN Xiaojun, ZHOU Sha, QIU Jingfan, CHEN Lin, XU Zhipeng, JI Minjun, GUO Jing, ZHANG Rong. Application of the “virtual⁃real combination” experimental teaching model in Human Parasitology teaching: a case study of comprehensive schistosome experiments [J]. Chinese Journal of Schistosomiasis Control, 2023, 35(2): 180-.
[4]	XU Jing, LI Yi⁃feng, DONG Yi, ZHAO Zheng⁃yuan, WEN Li⁃yong, ZHANG Shi⁃qing, LIN Dan⁃dan, ZHOU Jie, LIANG Song, GUO Jia⁃gang, LI Shi⁃zhu, ZHOU Xiao⁃nong. Decoding the evolution of preventive chemotherapy schemes for schistosomiasis in China to improve the precise implementation of the WHO guideline on control and elimination of human schistosomiasis [J]. Chinese Journal of Schistosomiasis Control, 2022, 34(3): 223-.
[5]	Yang Rui⁃bing, Li Yun⁃zhen, Su Kun⁃hua, Wang Li⁃fu, Li Ling. Advances in studies on schistosome⁃host interactions mediated by extracellular vesicles [J]. Chinese Journal of Schistosomiasis Control, 2022, 34(3): 318-.
[6]	QU Lei, MA Song⁃cui, XU Li⁃li, JIANG Xin⁃ze, SUN Xue⁃wei, DONG Zhou⁃yan, WU Yu⁃long. Whole transcriptome analysis and critical gene regulatory network analysis during Schistosoma japonicum infection and praziquantel treatment in mice [J]. Chinese Journal of Schistosomiasis Control, 2022, 34(2): 128-.
[7]	YUAN Xuan, ZHANG Su⁃yang, YAO Jia⁃kai, XING Yun⁃tian, QU Guo⁃li, LIANG You⁃sheng, DAI Jian⁃rong. Effects of praziquantel isomers on the proliferation and activation of the LX⁃2 human hepatic stellate cell line [J]. Chinese Journal of Schistosomiasis Control, 2022, 34(1): 75-.
[8]	ZHAN Na, LIU Xing⁃Hai, TANG Fang⁃Ying, ZHANG Jian⁃Yong. Identification of potential targets and synergistic mechanism of Kushen Decoction for the treatment of cryptosporidiosis [J]. Chinese Journal of Schistosomiasis Control, 2021, 33(5): 483-.
[9]	QU Guo⁃Li, LIANG You⁃Sheng, DAI Jian⁃Rong, SHI Feng, XING Yun⁃Tian, SHEN Xue⁃Hui, GUO Na. Studies on resistance of Schistosoma to praziquantel XⅧ Sensitivity to praziquantel in filial generations of praziquantel⁃resistant and ⁃sensitive Schistosoma japonicum mixed infections [J]. Chinese Journal of Schistosomiasis Control, 2021, 33(5): 505-.
[10]	YUAN Xuan, DAI Jian⁃Rong. Progress of researches on the actions of praziquantel against hepatic fibrosis [J]. Chinese Journal of Schistosomiasis Control, 2021, 33(5): 540-.
[11]	XIAO Ning. Concept and mechanism innovations provide a sustainable driver for echinococcosis control in China [J]. Chinese Journal of Schistosomiasis Control, 2021, 33(4): 329-.
[12]	WANG Li-Ping, DENG Wang-Ping, JIA Tie-Wu, QIN Zhi-Qiang, XU Jing. Conversion of serum anti-Schistosoma japonicum antibodies detected by immunological tests following treatment with praziquantel: a meta-analysis [J]. Chin J Schisto Control, 2021, 33(2): 138-.
[13]	SHI Qian-Wen, GU Jun, SHEN Ling-E, ZHOU Jing, GUO Feng, WANG Hai-Tao. Imported schistosomiasis haematobia in Suzhou City: a case report [J]. Chin J Schisto Control, 2019, 31(4): 453-.
[14]	SHEN Ji-Long, YU Li. Prevalence and fundamental researches of prevention and treatment of toxoplasmosis in China: an overview [J]. Chin J Schisto Control, 2019, 31(1): 71-76.
[15]	LIAO Yao, SUN Xi, WU Zhong-Dao. Advances in pathogenic mechanisms of Angiostrongylus cantonensis infection [J]. Chin J Schisto Control, 2019, 31(1): 98-102.

Arcanum of mechanism of praziquantel against schistosomes

吡喹酮抗血吸虫作用机理的奥秘

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics